Premium
The first love, you never forget. The last heart valve, you might remember better than the first
Author(s) -
Aranzulla Tiziana Claudia,
Musumeci Giuseppe
Publication year - 2020
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.28873
Subject(s) - medicine , valve replacement , cardiology , aortic valve , heart valve , stroke (engine) , surgery , stenosis , mechanical engineering , engineering
Key Points Valve‐in‐valve (VIV) transcatheter aortic valve replacement (TAVR) does not increase cerebrovascular risk compared with TAVR in native aortic valves; the only predictors of new brain lesions were age and postdilatation. Wise choice of the biological valve at the time of surgical aortic replacement, routine use of cerebral protection devices, and new therapeutic paths may be important. Larger studies are needed, hopefully with systematic postdilatation or bioprosthetic valve fracture in cases of residual high transvalvular gradients after VIV TAVR.